Quality approaches to allow multi-site equivalence in pluripotent stem cell based product manufacturing [Abstract]

This paper was presented at the annual conference of the British-Society-for-Gene-and-Cell-Therapy / Joint UK-Regenerative-Medicine-Platform Meeting, Royal Welsh Coll Mus & Drama, Cardiff, WALES, April 19–April 21. Final publication is available from Mary Ann Liebert, Inc., publishers https://doi.org/10.1089/hum.2017.29044.abstracts